SRE | ||
---|---|---|
OUTLOOK RATING 1..100 | 16 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 38 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 49 | |
P/E GROWTH RATING 1..100 | 48 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NFRA | SRE | |
---|---|---|
RSI ODDS (%) | N/A | 1 day ago51% |
Stochastic ODDS (%) | 1 day ago80% | 1 day ago44% |
Momentum ODDS (%) | 1 day ago80% | 1 day ago53% |
MACD ODDS (%) | 1 day ago76% | 1 day ago52% |
TrendWeek ODDS (%) | 1 day ago79% | 1 day ago52% |
TrendMonth ODDS (%) | 1 day ago73% | 1 day ago50% |
Advances ODDS (%) | 1 day ago77% | 5 days ago55% |
Declines ODDS (%) | 5 days ago75% | 21 days ago49% |
BollingerBands ODDS (%) | 5 days ago69% | 1 day ago57% |
Aroon ODDS (%) | 1 day ago79% | 1 day ago45% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MMSC | 21.11 | 0.41 | +1.98% |
First Trust Multi-Manager Sm Cp Opps ETF | |||
FELG | 38.13 | 0.74 | +1.98% |
Fidelity Enhanced Large Cap Growth ETF | |||
IBGK | 23.80 | 0.40 | +1.72% |
iShares iBonds Dec 2054 Term Trsy ETF | |||
PPH | 85.65 | 1.13 | +1.34% |
VanEck Pharmaceutical ETF | |||
BNOV | 41.94 | 0.45 | +1.08% |
Innovator US Equity Buffer ETF Nov |
A.I.dvisor indicates that over the last year, NFRA has been loosely correlated with DTE. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if NFRA jumps, then DTE could also see price increases.
Ticker / NAME | Correlation To NFRA | 1D Price Change % | ||
---|---|---|---|---|
NFRA | 100% | +1.15% | ||
DTE - NFRA | 64% Loosely correlated | +1.65% | ||
HTO - NFRA | 64% Loosely correlated | +0.57% | ||
ADP - NFRA | 64% Loosely correlated | -2.34% | ||
SRE - NFRA | 63% Loosely correlated | +2.48% | ||
ENB - NFRA | 63% Loosely correlated | +0.91% | ||
More |